VariZig is a Intramuscular Solution in the Human Prescription Drug category. It is labeled and distributed by Saol Therapeutics Inc.. The primary component is Human Varicella-zoster Immune Globulin.
Product ID | 70257-126_272379b7-f0e7-4560-8d79-3fd0024c3010 |
NDC | 70257-126 |
Product Type | Human Prescription Drug |
Proprietary Name | VariZig |
Generic Name | Varicella Zoster Immune Globulin (human) |
Dosage Form | Solution |
Route of Administration | INTRAMUSCULAR |
Marketing Start Date | 2019-03-01 |
Marketing Category | BLA / BLA |
Application Number | BLA125430 |
Labeler Name | Saol Therapeutics Inc. |
Substance Name | HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN |
Active Ingredient Strength | 125 [iU]/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2019-03-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125430 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-03-01 |
Marketing Category | BLA |
Application Number | BLA125430 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-03-01 |
Ingredient | Strength |
---|---|
HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN | 125 [iU]/mL |
SPL SET ID: | 1cec80c5-a2b3-459f-959e-d6febfd2671c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
53270-0126 | VARIZIG | Varicella Zoster Immune Globulin (Human) |
70257-126 | VariZig | Varicella Zoster Immune Globulin (Human) |
70504-0126 | VARIZIG | Varicella Zoster Immune Globulin (Human) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VARIZIG 78679351 3240650 Live/Registered |
SAOL INTERNATIONAL LIMITED 2005-07-27 |
VARIZIG 75934913 not registered Dead/Abandoned |
Cangene Corporation 2000-03-03 |